You just read:

Prometic Announces Positive Long Term Clinical Data on Ryplazym™ in Plasminogen Congenital Deficiency and Provides Regulatory Update

News provided by

ProMetic Life Sciences Inc.

Jul 11, 2017, 06:30 ET